SPA-10091-HCl

N/A

Report date: 2025/04/29 16:10:12
NME

Base Information

Drug NameSPA-10091-HCl
Drug Alias NameSPA-10091-HCl
ClassificationSmall molecules
Mechanisms of ActionDOT1 like histone lysine methyltransferase inhibitors
TargetsDOT1 like histone lysine methyltransferase
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A